Cystic fibrosis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
* '''Sweat chloride test:''' This test is an indicator of CFTR function and measures the chloride content of the sweat in the patients with cystic fibrosis. Sweat chloride test is critical to distinguish cystic fibrosis from other causes of severe pulmonary and pancreatic insufficiencies. | * '''Sweat chloride test:''' This test is an indicator of CFTR function and measures the chloride content of the sweat in the patients with cystic fibrosis. Sweat chloride test is critical to distinguish cystic fibrosis from other causes of severe pulmonary and pancreatic insufficiencies. | ||
** A sweat chloride value of more than 60 mmol/L is diagnostic for cystic fibrosis. | ** A sweat chloride value of more than 60 mmol/L is diagnostic for cystic fibrosis. | ||
{{familytree/start |summary=Sweat chloride test}} | |||
{{familytree | | | | | | | | | A01 |A01=Sweat chloride test}} | |||
{{familytree | | | |,|-|-|-|-|-|+|-|-|-|-|-|.| | | }} | |||
{{familytree | | | B01 | | | | B02 | | | | B03 | | |B01=≥60 mmol/L|B02=30-59 mmol/L|B03=≤29 mmol/L}} | |||
{{familytree | | | |!| | | | | |!| | | | | |!| }} | |||
{{familytree | | | |!| | | | | C01 | | | | |!| | |C01=CFTR genetic analysis}} | |||
{{familytree | | | |!| | | | | |!| | | | | |!| }} | |||
{{familytree | | | |!| | | |,|-|^|-|.| | | |!| }} | |||
{{familytree | | | |!|,|-| D01 | | D02 |-|.|!| | |D01=2 CF-causing CFTR mutation|D02=No CFTR mutations}} | |||
{{familytree | | | |!|!| | | | | | | | | |!|!| }} | |||
{{familytree | | | |!|!| | | | | | | | | |!|!| }} | |||
{{familytree | | | E01 | | | | | | | | | | E02 |E01=EF diagnosis|E02=CF unlikely}} | |||
{{familytree/end}} | |||
*'''Nasal Potential Difference (NPD):''' In patients with cystic fibrosis NPD is performed by running different solutions through the nose. Voltage measurements from these solutions are used to detect changes in CFTR function. | *'''Nasal Potential Difference (NPD):''' In patients with cystic fibrosis NPD is performed by running different solutions through the nose. Voltage measurements from these solutions are used to detect changes in CFTR function. | ||
==References== | ==References== | ||
Revision as of 17:09, 23 February 2018
|
Cystic fibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cystic fibrosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Cystic fibrosis other diagnostic studies |
|
Risk calculators and risk factors for Cystic fibrosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Other diagnostic studies in patients with cystic fibrosis include sweat chloride test and nasal potential differences which used to detect changes in CFTR function.
Other Diagnostic Studies
Other diagnostic studies in patients with cystic fibrosis include:[1][2]
- Sweat chloride test: This test is an indicator of CFTR function and measures the chloride content of the sweat in the patients with cystic fibrosis. Sweat chloride test is critical to distinguish cystic fibrosis from other causes of severe pulmonary and pancreatic insufficiencies.
- A sweat chloride value of more than 60 mmol/L is diagnostic for cystic fibrosis.
| Sweat chloride test | |||||||||||||||||||||||||||||||||||||
| ≥60 mmol/L | 30-59 mmol/L | ≤29 mmol/L | |||||||||||||||||||||||||||||||||||
| CFTR genetic analysis | |||||||||||||||||||||||||||||||||||||
| 2 CF-causing CFTR mutation | No CFTR mutations | ||||||||||||||||||||||||||||||||||||
| EF diagnosis | CF unlikely | ||||||||||||||||||||||||||||||||||||
- Nasal Potential Difference (NPD): In patients with cystic fibrosis NPD is performed by running different solutions through the nose. Voltage measurements from these solutions are used to detect changes in CFTR function.
References
- ↑ Pettit RS, Fellner C (July 2014). "CFTR Modulators for the Treatment of Cystic Fibrosis". P T. 39 (7): 500–11. PMC 4103577. PMID 25083129.
- ↑ Shah U, Moatter T (2006). "Screening for cystic fibrosis: the importance of using the correct tools". J Ayub Med Coll Abbottabad. 18 (1): 7–10. PMID 16773960.